21 participants
GEMOX-HAIC Plus GEM-SYS in Combination With Lenvatinib and PD-1 Inhibitor for Large Unresectable ICC
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2024-07-17
- Start Date:
- 2024-07-10
- Completion:
- 2025-07-10
Conditions
- Intrahepatic Cholangiocarcinoma
Interventions
- DRUG
No Results Yet